Antonella Franch

Dr. Antonella Franch


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 December 2015 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
AFAntonella Franch
Antonella Franch
FBFederica Birattari
Federica Birattari
GMGloria Dal Mas
Gloria Dal Mas
ZALA LUZNIK MARZIDOVSEKZALA LUZNIK MARZIDOVSEK
ZALA LUZNIK MARZIDOVSEK
MPMohit Parekh
Mohit Parekh
DPDiego Ponzin
Diego Ponzin
Purpose. To compare stromal riboflavin concentration after three corneal cross-linking (CXL) imbibition procedures: standard (EpiOff), transepithelial corneal (EpiOn), and iontophoresis-assisted technique (Ionto) using 0.1% hypotonic riboflavin phosphate.Methods. Randomized open-label pilot clinical study. Twelve corneas/12 patients with advanced keratoconus were randomly divided into 4 groups for CXL (n=3). The corneas underwent imbibition with standard riboflavin EpiOff and with enhanced riboflavin solution (RICROLIN+) EpiOff, EpiOn, and iontophoresis techniques. Thereafter, deep anterior lamellar keratectomy procedure was performed and the obtained debrided corneal tissues were frozen. The maximal intrastromal riboflavin concentration was measured by high-performance liquid chromatography/mass spectrometry (mcg/dg).Results. The mean stromal concentration of riboflavin was2.02±0.72mcg/dg in EpiOff group,4.33±0.12mcg/g in EpiOff-RICROLIN+ group,0.63±0.21mcg/dg in EpiOn-RICROLIN+ group, and1.15±0.27mcg/dg in iontophoresis RICROLIN+ group. A 7-fold decrease in intrastromal riboflavin concentration was observed comparing EpiOn-RICROLIN+ and EpiOff-RICROLIN+ groups.Conclusion. The present pilot study indicates that both transepithelial CXL techniques in combination with hypotonic enhanced riboflavin formulation (RICROLIN+) were still inferior to the standard CXL technique; however, larger clinical studies to further validate the results are needed and in progress.

30 October 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PAPasquale Aragona
Pasquale Aragona
Giuseppe GiannaccareGiuseppe Giannaccare
Giuseppe Giannaccare
RMRita Mencucci
Rita Mencucci
PRPierangela Rubino
Pierangela Rubino
ECEmilia Cantera
Emilia Cantera
MRMaurizio Rolando
Maurizio Rolando
Dry eye disease (DED) is a highly prevalent, chronic and progressive condition that affects 5–33% of the world’s adult population

22 August 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PLPia Leon
Pia Leon
LFLorena Francescutti
Lorena Francescutti
PGPietro Gentile
Pietro Gentile
FBFederica Birattari
Federica Birattari
DPDiego Ponzin
Diego Ponzin
MPMohit Parekh
Mohit Parekh
Objective: We sought to evaluate the clinical outcomes of hemi-UT-DSAEK grafts from the pediatric donor corneas of patients affected by Fuchs Endothelial Corneal Dystrophy (FECD). Methods: A prospective, interventional case series was conducted at the Ophthalmology Department of Venice Civil Hospital and the Veneto Eye Bank Foundation (Venice, Italy). Six eyes of six patients affected by FECD received large-diameter, semicircular hemi-UT-DSAEK grafts obtained from three pediatric donor corneas using the standard pull-through method. Endothelial cell density (ECD), central corneal thickness (CCT), best-corrected visual acuity (BCVA) and intraoperative and postoperative complications were recorded at different time intervals up to 12 months. Results: The average donor age was 64.6 ± 8.6 years, and the pre-operative ECD was 3266 ± 225 cells/mm2. At 12 months postoperatively, the average ECD was 1376 ± 509 cells/mm2 with a mean decrease of 56.8 ± 19.1% from the preoperative donor count. At 12 months, four out of six eyes had significantly improved and reached a BCVA of ≥20/25 (Snellen equivalent). The mean CCT significantly decreased from 788 ± 138 μm before surgery to 576 ± 30 μm at 12 months postoperatively (p < 0.01). Conclusions: Hemi-UT-DSAEK grafts using pediatric donor corneas are surgically feasible and can provide similar clinical outcomes compared to conventional UT-DSAEK. Transplanting pediatric donor tissues with high ECD into two patients could potentially increase the donor tissue pool to treat endothelial disease.